Pulmonary vein stenosis (PVS) may arise from a variety of conditions and result in major
morbidity and mortality. In some patients, pharmacologic therapy may help, but more often in …

Pulmonary vein stenosis (PVS) can arise from several etiologies, including congenital,
acquired, and iatrogenic sources. PVS presents insidiously, leading to significant delays in …

Abstract Purpose of Review Pulmonary vein stenosis (PVS) is a rare entity that until the last
2 decades was seen primarily in infants and children. Percutaneous and surgical …

Vascular cell overgrowth and lumen size reduction in pulmonary vein stenosis (PVS) can
result in elevated PV pressure, pulmonary hypertension, cardiac failure, and death …

Pulmonary vein stenosis (PVS) is a rare condition that is either congenital or acquired and
carries a high risk of morbidity and mortality. Depending on the severity of stenosis and …

Background Current therapies for pulmonary vein stenosis (PVS) or pulmonary vein total
occlusion (PVTO) involving angioplasty and stenting are hindered by high rates of …

Background: Pulmonary vein (PV) stenosis (PVS) is a serious complication of atrial
fibrillation (AF) ablation. The objective of this study was to describe interventional treatments …

Pulmonary vein stenosis (PVS) can occasionally occur in the follow-up after pulmonary vein
isolation (PVI) for atrial fibrillation (AF). During PVI, ablation is performed at the PV ostium or …

Background Pulmonary veins stenosis (PVS) after atrial fibrillation radiofrequency ablation is
an uncommon complication. When it occurs, percutaneous treatment is the preferred …

Pulmonary vein stenosis (PVS) is an extremely rare and lethal disease caused by multiple
etiologies. PVS has a bimodal distribution in the population, affecting children and adults …